Alpha Teknova (TKNO) Income towards Parent Company (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Income towards Parent Company came in at -$4.6 million in Q1 2026, up 1.94% year-on-year from -$4.5 million in Q1 2025, and up 3.64% on a QoQ basis from -$4.7 million in Q4 2025.
Alpha Teknova (TKNO) Income towards Parent Company (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Income towards Parent Company data on file, last reported at -$4.6 million in Q1 2026.
- On a quarterly basis, Income towards Parent Company rose 1.94% year-over-year to -$4.6 million in Q1 2026; TTM through Mar 2026 was -$17.2 million, a 26.33% increase from a year earlier, with the FY2025 full-year figure at -$17.2 million, up 35.66% from the prior year.
- Income towards Parent Company for Q1 2026 stood at -$4.6 million, up from -$4.7 million in the prior quarter.
- Over the last five years, Income towards Parent Company for TKNO reached as high as -$3.6 million in Q2 2025 and fell as low as -$22.4 million in Q3 2022.
- Historically, Income towards Parent Company has averaged -$7.9 million across 5 years, with a median of -$6.2 million in 2022.
- Across the five-year window, Income towards Parent Company sank 732.98% in 2022 and jumped 54.77% in 2023, its largest moves.
- Year by year, Income towards Parent Company stood at -$15.2 million in 2022, then climbed by 27.88% to -$11.0 million in 2023, then soared by 47.82% to -$5.7 million in 2024, then advanced by 17.35% to -$4.7 million in 2025, then gained by 3.64% to -$4.6 million in 2026.
- Per Business Quant data, the three most recent Income towards Parent Company figures were -$4.6 million in Q1 2026, -$4.7 million in Q4 2025, and -$4.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.54 Bn | 20.54 Bn | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn |
| 10 | Alpha Teknova | 259.99 Mn | 242.21 Mn | 3.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.56 Mn |
| Dec 31, 2025 | -4.73 Mn |
| Sep 30, 2025 | -4.31 Mn |
| Jun 30, 2025 | -3.57 Mn |
| Mar 31, 2025 | -4.65 Mn |
| Dec 31, 2024 | -5.72 Mn |
| Sep 30, 2024 | -7.57 Mn |
| Jun 30, 2024 | -5.36 Mn |
| Mar 31, 2024 | -8.10 Mn |
| Dec 31, 2023 | -10.96 Mn |
| Sep 30, 2023 | -10.15 Mn |
| Jun 30, 2023 | -7.15 Mn |
| Mar 31, 2023 | -8.82 Mn |
| Dec 31, 2022 | -15.20 Mn |
| Sep 30, 2022 | -22.45 Mn |
| Jun 30, 2022 | -6.20 Mn |
| Mar 31, 2022 | -5.46 Mn |
| Dec 31, 2021 | -6.48 Mn |
| Sep 30, 2021 | -3.24 Mn |
| Jun 30, 2021 | -2.23 Mn |